Delivery Order SPE2DR25D3003-SPE2DR26F5QV9
- Not listed
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $1,709.28 for M-M-R II vaccine vials, with an ultimate completion date of November 25, 2025. This is a firm fixed-price contract with no set-aside designation, competitively awarded to the Conshohocken, Pennsylvania-based pharmaceutical distributor. The place of performance is AmerisourceBergen's corporate office location in Conshohocken. This delivery order is issued under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded a $1,766.37 firm fixed-price delivery order to AmerisourceBergen Drug Corp for M-M-R II vaccine vials, with a performance location in Conshohocken, Pennsylvania and an ultimate completion date of January 21, 2026. This non-set-aside competitive award represents a task order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical, valued at up to $999,999,999.00 through December 2026. The parent company, Cencora, Inc....
- The Defense Logistics Agency awarded a delivery order valued at $1,581.65 to AmerisourceBergen Drug Corp for M-M-R II vaccine vials, with an ultimate completion date of January 12, 2026. This competitively awarded, firm fixed-price contract represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (valued at $999,999,999.00 through December 2026), which serves as a comprehensive global pharmaceutical support vehicle for military...
- The Defense Logistics Agency awarded a delivery order valued at $1,139.62 to AmerisourceBergen Drug Corp for M-M-R II vaccine vials. This contract employs firm fixed price terms with an ultimate completion date of November 25, 2025, and was awarded competitively without a set-aside designation. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC)...
- The Defense Logistics Agency awarded a delivery order valued at $7,720.60 to AmerisourceBergen Drug Corp for M-M-R II vaccine vials, with an ultimate completion date of August 19, 2025. This competitive award utilizes firm fixed pricing and carries no set-aside designation. The place of performance is located in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. This delivery order is issued as a child contract under the company's larger Indefinite Delivery...
- The Defense Logistics Agency awarded a delivery order valued at $1,729.69 to AmerisourceBergen Drug Corp for M-M-R II vaccine vials, with an ultimate completion date of January 15, 2026. The contract is structured as a firm fixed-price delivery order with no set-aside designation, indicating it was competitively awarded. The place of performance is located in Conshohocken, Pennsylvania, which serves as the corporate headquarters for the awardee. This delivery order represents a task order issued...
- The Defense Logistics Agency awarded a $2,263.10 delivery order to AmerisourceBergen Drug Corp for M-M-R II vaccine vials under a firm fixed price contract. The order was competitively awarded without set-aside designation and is scheduled for completion by December 11, 2025. AmerisourceBergen, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location in the same city. This delivery order is issued under...
- The Defense Logistics Agency awarded a $3,736.44 firm fixed price delivery order to AmerisourceBergen Drug Corp for M-M-R II vaccine vials on June 4, 2025, with an ultimate completion date of June 5, 2025. The contract was competitively awarded with no set-aside designation and will be performed at the contractor's corporate office in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical,...
- The Defense Logistics Agency awarded a delivery order contract valued at $18,016.80 to AmerisourceBergen Drug Corp for M-M-R II vaccine vials on August 5, 2025, with an ultimate completion date of August 6, 2025. This is a firm fixed-price delivery order issued under a non-set-aside competitive procurement. The contract is being performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a child contract under AmerisourceBergen's...
- The Defense Logistics Agency awarded a $31,839.65 delivery order to AmerisourceBergen Drug Corp for M-M-R II vaccine vials on January 7, 2026, with a completion date of January 8, 2026. This firm fixed-price contract was competitively awarded with no set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp operates as a subsidiary of Cencora, Inc., a major pharmaceutical distributor serving critical federal medical...
- SPE2DR25D3003Indefinite Delivery Contract
- SPE2DR25D3003-SPE2DR26F5QV9Delivery Order
The Defense Logistics Agency awarded a $1,177.58 firm fixed-price delivery order to AmerisourceBergen Drug Corp for M-M-R II vaccine vials, with a completion date of January 22, 2026. This non-set-aside contract represents a single delivery order issued under AmerisourceBergen's broader pharmaceutical supply relationship with the federal government. The place of performance is located in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters and primary distribution operations. This delivery order is issued under AmerisourceBergen's Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, a comprehensive $999,999,999 vehicle established through December 2026 that enables the company to supply a wide range of pharmaceutical products and medical supplies to support military healthcare programs globally. AmerisourceBergen operates as a subsidiary of parent company Cencora, Inc., which holds the primary IDC with DLA. The M-M-R II vaccine procurement supports the Defense Health Agency and military treatment facilities' immunization requirements, reflecting the Defense Logistics Agency's critical role in ensuring consistent pharmaceutical availability across the military healthcare system.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.2k | 1/20/26 |